Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma
NCT01272466
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Relapsed Multiple Myeloma
Interventions
BIOLOGICAL:
peptides derived from antiapoptotic proteins
Sponsor
Herlev Hospital
Collaborators
[object Object]